nodes	percent_of_prediction	percent_of_DWPC	metapath
Clenbuterol—TNF—urinary bladder cancer	0.804	1	CbGaD
Clenbuterol—NGF—prostate gland—urinary bladder cancer	0.00921	0.21	CbGeAlD
Clenbuterol—ADRB3—prostate gland—urinary bladder cancer	0.00586	0.134	CbGeAlD
Clenbuterol—TNF—vagina—urinary bladder cancer	0.00492	0.112	CbGeAlD
Clenbuterol—CYP1A2—urine—urinary bladder cancer	0.00437	0.0997	CbGeAlD
Clenbuterol—ADRB3—female reproductive system—urinary bladder cancer	0.0032	0.0731	CbGeAlD
Clenbuterol—TNF—lymph node—urinary bladder cancer	0.00319	0.0728	CbGeAlD
Clenbuterol—NGF—lymph node—urinary bladder cancer	0.00294	0.0671	CbGeAlD
Clenbuterol—ADRB1—prostate gland—urinary bladder cancer	0.0024	0.0547	CbGeAlD
Clenbuterol—ADRB1—female reproductive system—urinary bladder cancer	0.00131	0.0299	CbGeAlD
Clenbuterol—CYP1A1—epithelium—urinary bladder cancer	0.00114	0.0259	CbGeAlD
Clenbuterol—CYP1A2—renal system—urinary bladder cancer	0.00107	0.0244	CbGeAlD
Clenbuterol—CYP1A1—renal system—urinary bladder cancer	0.00105	0.0241	CbGeAlD
Clenbuterol—CYP1A1—urethra—urinary bladder cancer	0.00103	0.0236	CbGeAlD
Clenbuterol—CYP1A1—female reproductive system—urinary bladder cancer	0.000844	0.0193	CbGeAlD
Clenbuterol—CYP1A1—vagina—urinary bladder cancer	0.000763	0.0174	CbGeAlD
Clenbuterol—CYP1A1—lymph node—urinary bladder cancer	0.000494	0.0113	CbGeAlD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—urinary bladder cancer	8.93e-05	0.000585	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	8.93e-05	0.000585	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	8.87e-05	0.000582	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—urinary bladder cancer	8.68e-05	0.000569	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	8.68e-05	0.000569	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—GLI1—urinary bladder cancer	8.62e-05	0.000565	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—TP53—urinary bladder cancer	8.59e-05	0.000563	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	8.58e-05	0.000563	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	8.56e-05	0.000561	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—S100B—urinary bladder cancer	8.27e-05	0.000542	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	8.17e-05	0.000535	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—NCOR1—urinary bladder cancer	8.14e-05	0.000534	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	7.94e-05	0.000521	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—MYC—urinary bladder cancer	7.89e-05	0.000517	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	7.78e-05	0.00051	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	7.75e-05	0.000508	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—EGFR—urinary bladder cancer	7.71e-05	0.000506	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	7.61e-05	0.000499	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	7.61e-05	0.000499	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—NCOR1—urinary bladder cancer	7.44e-05	0.000488	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—KRAS—urinary bladder cancer	7.29e-05	0.000478	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	7.25e-05	0.000475	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	7.25e-05	0.000475	CbGpPWpGaD
Clenbuterol—CYP1A2—Biological oxidations—GSTP1—urinary bladder cancer	7.21e-05	0.000473	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	7.19e-05	0.000471	CbGpPWpGaD
Clenbuterol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—urinary bladder cancer	7.18e-05	0.000471	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	7.12e-05	0.000466	CbGpPWpGaD
Clenbuterol—CYP1A2—Metapathway biotransformation—GSTP1—urinary bladder cancer	7.11e-05	0.000466	CbGpPWpGaD
Clenbuterol—CYP1A1—PPARA activates gene expression—EP300—urinary bladder cancer	6.97e-05	0.000457	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	6.96e-05	0.000456	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—CXCL8—urinary bladder cancer	6.94e-05	0.000455	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GSTZ1—urinary bladder cancer	6.93e-05	0.000454	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis—TP53—urinary bladder cancer	6.91e-05	0.000453	CbGpPWpGaD
Clenbuterol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—urinary bladder cancer	6.9e-05	0.000452	CbGpPWpGaD
Clenbuterol—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—urinary bladder cancer	6.82e-05	0.000447	CbGpPWpGaD
Clenbuterol—CYP1A2—Biological oxidations—GSTM1—urinary bladder cancer	6.63e-05	0.000434	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	6.58e-05	0.000431	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GSTO2—urinary bladder cancer	6.57e-05	0.000431	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—NAT1—urinary bladder cancer	6.57e-05	0.000431	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—TERT—urinary bladder cancer	6.56e-05	0.00043	CbGpPWpGaD
Clenbuterol—CYP1A2—Metapathway biotransformation—GSTM1—urinary bladder cancer	6.54e-05	0.000429	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—TP53—urinary bladder cancer	6.48e-05	0.000424	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	6.46e-05	0.000424	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—CDK4—urinary bladder cancer	6.42e-05	0.000421	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	6.11e-05	0.0004	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—HDAC4—urinary bladder cancer	6.1e-05	0.0004	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—FGFR3—urinary bladder cancer	6.02e-05	0.000394	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—UGT2B7—urinary bladder cancer	6.01e-05	0.000394	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—HDAC4—urinary bladder cancer	5.97e-05	0.000391	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—RBX1—urinary bladder cancer	5.91e-05	0.000387	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	5.84e-05	0.000383	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—ESR1—urinary bladder cancer	5.84e-05	0.000383	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—PPARG—urinary bladder cancer	5.84e-05	0.000383	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—CREBBP—urinary bladder cancer	5.61e-05	0.000367	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TSC1—urinary bladder cancer	5.55e-05	0.000364	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CYP4B1—urinary bladder cancer	5.41e-05	0.000355	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—urinary bladder cancer	5.41e-05	0.000355	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—urinary bladder cancer	5.29e-05	0.000347	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—JAG1—urinary bladder cancer	5.29e-05	0.000346	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CREBBP—urinary bladder cancer	5.12e-05	0.000336	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—GLI1—urinary bladder cancer	5.11e-05	0.000335	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—SLC19A1—urinary bladder cancer	5.11e-05	0.000335	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—RHOA—urinary bladder cancer	5.07e-05	0.000332	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—IGF1—urinary bladder cancer	5.06e-05	0.000331	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—GLI1—urinary bladder cancer	5e-05	0.000328	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PRSS3—urinary bladder cancer	4.98e-05	0.000326	CbGpPWpGaD
Clenbuterol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—urinary bladder cancer	4.7e-05	0.000308	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—ERBB2—urinary bladder cancer	4.7e-05	0.000308	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—RHOA—urinary bladder cancer	4.63e-05	0.000304	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—RHOA—urinary bladder cancer	4.47e-05	0.000293	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	4.42e-05	0.00029	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—ERBB2—urinary bladder cancer	4.29e-05	0.000281	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—S100B—urinary bladder cancer	4.28e-05	0.000281	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	4.19e-05	0.000275	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—NAT1—urinary bladder cancer	4.19e-05	0.000275	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	4.12e-05	0.00027	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—CXCL8—urinary bladder cancer	4.12e-05	0.00027	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CXCL8—urinary bladder cancer	4.07e-05	0.000267	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—RHOA—urinary bladder cancer	4.06e-05	0.000266	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—CXCL8—urinary bladder cancer	4.03e-05	0.000264	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—MMP9—urinary bladder cancer	4.03e-05	0.000264	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.99e-05	0.000262	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—TYMP—urinary bladder cancer	3.98e-05	0.000261	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—CXCL8—urinary bladder cancer	3.92e-05	0.000257	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—IL2—urinary bladder cancer	3.89e-05	0.000255	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—NCOR1—urinary bladder cancer	3.85e-05	0.000252	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	3.83e-05	0.000251	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.82e-05	0.000251	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—EP300—urinary bladder cancer	3.82e-05	0.00025	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CCND1—urinary bladder cancer	3.79e-05	0.000248	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—IL2—urinary bladder cancer	3.75e-05	0.000246	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—SRC—urinary bladder cancer	3.71e-05	0.000243	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—MMP9—urinary bladder cancer	3.68e-05	0.000241	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CDKN1A—urinary bladder cancer	3.67e-05	0.00024	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—PTEN—urinary bladder cancer	3.66e-05	0.00024	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—NAT2—urinary bladder cancer	3.6e-05	0.000236	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—CXCL8—urinary bladder cancer	3.56e-05	0.000233	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—RBX1—urinary bladder cancer	3.51e-05	0.00023	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—EP300—urinary bladder cancer	3.49e-05	0.000229	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	3.45e-05	0.000226	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—RBX1—urinary bladder cancer	3.43e-05	0.000225	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—IL2—urinary bladder cancer	3.4e-05	0.000223	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—SRC—urinary bladder cancer	3.39e-05	0.000222	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TERT—urinary bladder cancer	3.39e-05	0.000222	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TSC1—urinary bladder cancer	3.3e-05	0.000216	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	3.26e-05	0.000214	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—EGFR—urinary bladder cancer	3.25e-05	0.000213	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TSC1—urinary bladder cancer	3.22e-05	0.000211	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	3.17e-05	0.000208	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—JAG1—urinary bladder cancer	3.14e-05	0.000206	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—FGFR3—urinary bladder cancer	3.11e-05	0.000204	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—RRM2—urinary bladder cancer	3.11e-05	0.000204	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—KRAS—urinary bladder cancer	3.07e-05	0.000202	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—JAG1—urinary bladder cancer	3.07e-05	0.000201	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—MYC—urinary bladder cancer	3.04e-05	0.000199	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—ESR1—urinary bladder cancer	3.02e-05	0.000198	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—EGFR—urinary bladder cancer	2.97e-05	0.000195	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—HPGDS—urinary bladder cancer	2.88e-05	0.000189	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—ENO2—urinary bladder cancer	2.88e-05	0.000189	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.86e-05	0.000188	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—KRAS—urinary bladder cancer	2.81e-05	0.000184	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GSTT1—urinary bladder cancer	2.79e-05	0.000183	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.75e-05	0.00018	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—RHOA—urinary bladder cancer	2.65e-05	0.000174	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CREBBP—urinary bladder cancer	2.65e-05	0.000174	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—IGF1—urinary bladder cancer	2.62e-05	0.000171	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—HRAS—urinary bladder cancer	2.61e-05	0.000171	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—EGFR—urinary bladder cancer	2.6e-05	0.000171	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—RHOA—urinary bladder cancer	2.59e-05	0.00017	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.55e-05	0.000167	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—S100B—urinary bladder cancer	2.54e-05	0.000167	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—TYMP—urinary bladder cancer	2.54e-05	0.000166	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—TP53—urinary bladder cancer	2.5e-05	0.000164	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—S100B—urinary bladder cancer	2.49e-05	0.000163	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—KRAS—urinary bladder cancer	2.46e-05	0.000161	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.44e-05	0.00016	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—RHOA—urinary bladder cancer	2.41e-05	0.000158	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—RHOA—urinary bladder cancer	2.4e-05	0.000157	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—HRAS—urinary bladder cancer	2.39e-05	0.000156	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—RHOA—urinary bladder cancer	2.36e-05	0.000154	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—CXCL8—urinary bladder cancer	2.33e-05	0.000153	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—NQO1—urinary bladder cancer	2.32e-05	0.000152	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—NAT2—urinary bladder cancer	2.3e-05	0.00015	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NCOR1—urinary bladder cancer	2.28e-05	0.00015	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—CXCL8—urinary bladder cancer	2.28e-05	0.000149	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.25e-05	0.000148	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NCOR1—urinary bladder cancer	2.23e-05	0.000146	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—IL2—urinary bladder cancer	2.22e-05	0.000146	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—ERBB2—urinary bladder cancer	2.22e-05	0.000145	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—IL2—urinary bladder cancer	2.18e-05	0.000143	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CXCL8—urinary bladder cancer	2.11e-05	0.000139	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CXCL8—urinary bladder cancer	2.1e-05	0.000138	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—HRAS—urinary bladder cancer	2.09e-05	0.000137	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CXCL8—urinary bladder cancer	2.07e-05	0.000136	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—IL2—urinary bladder cancer	2.02e-05	0.000132	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TERT—urinary bladder cancer	2.01e-05	0.000132	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—IL2—urinary bladder cancer	2.01e-05	0.000132	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—RRM2—urinary bladder cancer	1.98e-05	0.00013	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—IL2—urinary bladder cancer	1.98e-05	0.00013	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TERT—urinary bladder cancer	1.97e-05	0.000129	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.96e-05	0.000129	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CCND1—urinary bladder cancer	1.96e-05	0.000128	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GSTP1—urinary bladder cancer	1.93e-05	0.000127	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MMP9—urinary bladder cancer	1.9e-05	0.000125	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CDKN1A—urinary bladder cancer	1.9e-05	0.000124	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PTEN—urinary bladder cancer	1.89e-05	0.000124	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.87e-05	0.000123	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—FGFR3—urinary bladder cancer	1.85e-05	0.000121	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ENO2—urinary bladder cancer	1.84e-05	0.00012	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	1.84e-05	0.00012	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.82e-05	0.00012	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—FGFR3—urinary bladder cancer	1.81e-05	0.000118	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—EP300—urinary bladder cancer	1.8e-05	0.000118	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—TYMS—urinary bladder cancer	1.8e-05	0.000118	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—ESR1—urinary bladder cancer	1.79e-05	0.000118	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	1.78e-05	0.000117	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—NCOR1—urinary bladder cancer	1.78e-05	0.000117	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GSTM1—urinary bladder cancer	1.78e-05	0.000117	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—ESR1—urinary bladder cancer	1.76e-05	0.000115	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—SRC—urinary bladder cancer	1.75e-05	0.000115	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.75e-05	0.000115	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GPX1—urinary bladder cancer	1.7e-05	0.000112	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—ERCC2—urinary bladder cancer	1.67e-05	0.00011	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CREBBP—urinary bladder cancer	1.57e-05	0.000103	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MYC—urinary bladder cancer	1.57e-05	0.000103	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—MTHFR—urinary bladder cancer	1.57e-05	0.000103	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IGF1—urinary bladder cancer	1.55e-05	0.000102	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—EGFR—urinary bladder cancer	1.55e-05	0.000101	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CREBBP—urinary bladder cancer	1.54e-05	0.000101	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—EGFR—urinary bladder cancer	1.54e-05	0.000101	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IGF1—urinary bladder cancer	1.52e-05	9.96e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—EGFR—urinary bladder cancer	1.51e-05	9.91e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—NQO1—urinary bladder cancer	1.48e-05	9.69e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—KRAS—urinary bladder cancer	1.46e-05	9.57e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—KRAS—urinary bladder cancer	1.45e-05	9.52e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.44e-05	9.41e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—KRAS—urinary bladder cancer	1.43e-05	9.36e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—RHOA—urinary bladder cancer	1.42e-05	9.32e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—RHOA—urinary bladder cancer	1.39e-05	9.12e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—ERBB2—urinary bladder cancer	1.32e-05	8.63e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TP53—urinary bladder cancer	1.29e-05	8.46e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—ERBB2—urinary bladder cancer	1.29e-05	8.44e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PPARG—urinary bladder cancer	1.27e-05	8.35e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.25e-05	8.2e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CXCL8—urinary bladder cancer	1.25e-05	8.19e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—HRAS—urinary bladder cancer	1.24e-05	8.13e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—HRAS—urinary bladder cancer	1.23e-05	8.09e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	1.23e-05	8.09e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CREBBP—urinary bladder cancer	1.22e-05	8.02e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CXCL8—urinary bladder cancer	1.22e-05	8.01e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—HRAS—urinary bladder cancer	1.21e-05	7.96e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.19e-05	7.82e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IL2—urinary bladder cancer	1.19e-05	7.82e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IL2—urinary bladder cancer	1.17e-05	7.65e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CCND1—urinary bladder cancer	1.16e-05	7.63e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—TYMS—urinary bladder cancer	1.15e-05	7.52e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CCND1—urinary bladder cancer	1.14e-05	7.46e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	1.13e-05	7.43e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	1.13e-05	7.43e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MMP9—urinary bladder cancer	1.13e-05	7.4e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CDKN1A—urinary bladder cancer	1.13e-05	7.38e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PTEN—urinary bladder cancer	1.12e-05	7.36e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MMP9—urinary bladder cancer	1.11e-05	7.24e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CDKN1A—urinary bladder cancer	1.1e-05	7.22e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PTEN—urinary bladder cancer	1.1e-05	7.2e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GPX1—urinary bladder cancer	1.09e-05	7.12e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—EP300—urinary bladder cancer	1.07e-05	7.02e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	1.07e-05	6.99e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—EP300—urinary bladder cancer	1.05e-05	6.87e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—SRC—urinary bladder cancer	1.04e-05	6.83e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—SRC—urinary bladder cancer	1.02e-05	6.68e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PTGS2—urinary bladder cancer	1e-05	6.57e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	1e-05	6.57e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MYC—urinary bladder cancer	9.33e-06	6.12e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MYC—urinary bladder cancer	9.13e-06	5.98e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—EGFR—urinary bladder cancer	9.13e-06	5.98e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—EGFR—urinary bladder cancer	8.93e-06	5.85e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PTEN—urinary bladder cancer	8.74e-06	5.73e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—KRAS—urinary bladder cancer	8.62e-06	5.65e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—KRAS—urinary bladder cancer	8.44e-06	5.53e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—EP300—urinary bladder cancer	8.34e-06	5.46e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PPARG—urinary bladder cancer	8.12e-06	5.33e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	7.8e-06	5.12e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TP53—urinary bladder cancer	7.66e-06	5.02e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TP53—urinary bladder cancer	7.5e-06	4.91e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—HRAS—urinary bladder cancer	7.33e-06	4.8e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—HRAS—urinary bladder cancer	7.17e-06	4.7e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	6.39e-06	4.19e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PTEN—urinary bladder cancer	5.57e-06	3.65e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—EP300—urinary bladder cancer	5.32e-06	3.48e-05	CbGpPWpGaD
